Investment in biomedical research centres from April 2017
Monday, 13 February 2017 13:49
NIHR Clinical Research Facilities 2017-2022
Monday, 13 February 2017 13:39
The NIHR has announced that, as of April 2017, the number of Clinical Research Facilities (CRFs) for early translational (experimental medicine) research will increase from 19 to 23. CRFs help speed up the translation of scientific advances for the benefit of patients. They are dedicated, purpose-built facilities where universities and NHS Trusts work together on patient-orientated commercial and non-commercial studies. CRFs are designed to support high-intensity studies, some of which involve overnight stays. A total of 112.3 million GBP will be invested in the English NHS infrastructure over a five-year period. This investment will provide crucial support for clinical research nurses, technicians and facility running costs. The investment is the result of the open competitive process that the NIHR launched in January 2016 to renew and refresh NIHR designation and funding for CRFs.
NIHR funding will meet the necessary recurrent NHS research infrastructure costs and NHS support costs for funded early translational (experimental medicine) research that needs to be undertaken in CRFs. Such costs include: research infrastructure staff (such as clinical and managerial leadership, data managers, and technical staff); NHS support costs (e.g. clinical research nurses, pharmacy, pathology, radiology); recurrent costs (e.g. consumables and travel); and indirect costs within the NHS (e.g. accommodation and payroll). Further details of the funding allocated can be found on the NIHR website.
Calling time on alcohol-related liver disease: top ten research priorities
Wednesday, 18 January 2017 14:29
Simon Denegri wrote a blog for the NIHR on the James Lind Alliance Alcohol-Related Liver Disease Priority Setting Partnership (PSP) which was funded by the NIHR and the BSG. The PSP brought together patients, carers and health professionals to identify the top ten research priorities for alcohol-related liver disease (listed and discussed in the blog). Simon is NIHR National Director for Patients and the Public in Research and Chair of INVOLVE.
New HRA approval leaflet
Wednesday, 30 November 2016 13:30
Page 10 of 40